We’re thrilled to share that our newly expanded NICU at Providence Holy Cross Medical Center was featured in the San Fernando Valley Sun, showcasing our increased capacity to care for the tiniest of humans.
Read the full article over at the newpaper's website:
Providence Holy Cross NICU Expands Number of Beds for Sick and Premature Infants - The San Fernando Valley Sun
Del survived Arctic winters, a demanding career and cancer – twice. Here’s how a pioneering Providence Cancer Institute trial helped him beat it a second time.
Providence Cancer Institute is enrolling patients with hepatocellular carcinoma in a trial of pumitamig, an investigational bispecific antibody.
Prestigious grants will help researchers pursue important cancer studies.
An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.
An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.
Advanced imaging technology allows clinicians to deliver targeted prostate cancer treatment while helping protect healthy tissue and reduce side effects. Dr. Amar Srivastava describes what's new.
A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.
When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.
Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.
Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.
How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.
New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.
Providence cancer researchers will use a $3.4-million federal grant to study why a new treatment regimen is showing better outcomes against tumors that have been difficult to treat in the past.
A new study focused on stories will change health outcomes for Black women.
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.
Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.
Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.
We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.
Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.
The study may redefine care for many people at the earliest stage of their treatment.